SIGLEC9 and urinary bladder cancer: We treated the bladder cancer cell line T24 with sialidase, which could cut α-2, 3 or 2, 6-linked sialic acid from glycan and compared the amount of binding Siglec9-Fc on the cell surface using flow cytometry analysis.